Skip to main content
2024 AANS Annual Scientific Meeting Main banner
Back

Elad I. Levy, MD, MBA (he/him/his)

Neurosurgeon
University at Buffalo Neurosurgery
Williamsville, NY, US

Elad I Levy is currently the Professor and Chair of Neurosurgery and the L. Nelson Hopkins Endowed Chair of the Department of Neurosurgery at SUNY Buffalo. He recently was awarded Distinguished Professor at the State University of New York at Buffalo. Dr. Levy graduated from Dartmouth College with a BS in Molecular Biology/Biochemistry in 1993. At Dartmouth, he competed as a varsity heavy weight rower. He graduated with distinction from the George Washington University School of Medicine and Health Sciences in 1997. Dr. Levy completed his resident training in neurosurgery at the University of Pittsburgh in 2004. As a recipient of the AANS/CNS Joint Cerebrovascular Section Mullen Endovascular Fellowship Award, he also completed a two year Endovascular Neurosurgery Fellowship with Dr. Nick Hopkins at SUNY Buffalo.
Dr. Levy has served on the CNS Executive Committee since 2007 and is the past president for the CNS Foundation and helped develop multiple global philanthropic initiatives. He recently served as President of the CNS 2022-2023, and in 2023 he served as the Vice Chair of the American Board of Neurological Surgeons and is the Endovascular Section Editor for Neurosurgery. His clinical and research interests are focused on treatment of cerebrovascular diseases, specifically aneurysm and stroke. He has coauthored over 600 peer reviewed papers and several books on cerebrovascular disease and treatment. In 2018 he received the Drake Lectureship Award, which recognizes contribution to advancing human knowledge and creativity. In 2023 he received the Clinical Trial Award established in Oracle for the sponsor Jacobs Institute. “Pipeline Flex-Shield Embolization Device Clinical Investigation plan- 30 day Dual Antipplated Therapy (DAPT) Followed by 365 Day Aspirin Early Feasibility Study.
Dr. Levy devotes his free time to his wife Cindy and their 3 children, Bennett, Hannon and Lauren. As a family they enjoy recreational and fitness activities outdoors.

Disclosure(s): ABNS: Board Member/Officer/Trustee (Ongoing); Claret Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Clarion: Consultant (Ongoing); CNS: Board Member/Officer/Trustee (Ongoing); Cognition Medical: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Endostream Medical : Advisor (Ongoing); GLG Consulting: Consultant (Ongoing); Guidepoint Global: Consultant (Ongoing); Haniva Technology: Board Member/Officer/Trustee (Ongoing); Imperative Care: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Integra: Speaker/Honoraria (Ongoing); IRRAS AB: Advisor (Ongoing); MEDICAL LEGAL REVIEW: Consultant (Ongoing), Ownership or Partnership (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Medtronic (STRATIS STUDY-SUB I): Grant/Research Support (Ongoing); MEDX: Advisor (Ongoing); Microvention: Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Microvention (CONFIDENCE STUDY): Grant/Research Support (Ongoing); MISIONIX: Consultant (Ongoing); Mosaic: Consultant (Ongoing); NextGen Biologics: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Speaker/Honoraria (Ongoing); Q'Apel: Stock Shareholder (excluding mutual funds) (Ongoing); Rapid Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Rebound Therapeutics: Stock Shareholder (excluding mutual funds) (Ongoing); StimMed: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); STRYKER AIS CLINICAL ADVISORY BOARD: Advisor (Ongoing); Three Rivers Medical: Stock Shareholder (excluding mutual funds) (Ongoing); UBNS: Board Member/Officer/Trustee (Ongoing)

Presentation(s):